SEC Form 4 · accession 0002063957-26-000005
Avalo Therapeutics, Inc. · AVTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ron M Philip
Director
Period of report
Jun 23, 2026
Accepted (ET)
Jun 25, 2026 · 5:24 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001534120
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $17.83 | Jun 23, 2026 | A | 40,200 | A | — | Jun 23, 2036 | Common Stock | 40,200 | 40,200 | D |
Explanation of responses
- F1The stock option vests in three substantially equal annual installments on the first, second and third anniversary of the date of grant, subject to the Eligible Director's continued service on each such vesting date.